Largest ever ‘map’ of autism may hold clues for new targeted therapies

Key Points:

• Researchers at UCSF have created the largest molecular map to date showing how genetic mutations associated with autism rewire protein interactions in the developing brain, using AI and lab-grown brain organoids.
• The study reveals over 1,800 autism-linked protein-protein interactions, 87% of which were previously unknown, providing a new blueprint to target protein interactions rather than individual genes for potential therapies.
• This molecular map may lead to more targeted drug development for autism, particularly for profound autism cases, and could also inform treatments for other neuropsychiatric disorders like schizophrenia and OCD.
• Experts hail the study as a watershed moment in autism science, offering hope for precision medicine that addresses underlying biology rather than symptoms, though translating findings into therapies will require significant further research.
• There is some debate about the direction of federal autism research funding, with concerns that current strategic plans may underemphasize genetic and neurobiological approaches despite the promising insights from this study.